World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
24234
World Ranking
11929
National Ranking
6119

Overview

Farrokh Dehdashti is affiliated with Washington University in St. Louis, United States. Their research primarily focuses on medical imaging, nuclear medicine, and oncology, contributing extensively to the field of Medicine with over 100 publications.

Their work spans several subfields, including:

  • Radiology, Nuclear Medicine and Imaging
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Obstetrics and Gynecology
  • Epidemiology

Key topics of Dehdashti's research encompass:

  • Medical Imaging Techniques and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Endometrial and Cervical Cancer Treatments
  • Breast Cancer Treatment Studies
  • Prostate Cancer Treatment and Research
  • Cervical Cancer and HPV Research

Frequently publishing in notable venues, their work appears in:

  • Journal of Nuclear Medicine
  • European Journal of Nuclear Medicine and Molecular Imaging
  • European Journal of Clinical Investigation
  • Clinical Cancer Research
  • International Journal of Radiation Oncology*Biology*Physics

Farrokh Dehdashti has collaborated regularly with several co-authors, including:

  • Barry A. Siegel
  • Richard L. Wahl
  • Richard Laforest
  • Ashwin Singh Parihar
  • Julie K. Schwarz

Some of their recent publications are:

  • Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy, 2021, Nature Communications
  • CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma, 2021, ACS Nano
  • Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival, 2020, Gynecologic Oncology
  • Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-18F-Fluoro-17β-Fluoroestradiol, 2023, Journal of Nuclear Medicine

Best Publications

  • Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).

    Felix G. Fernandez;Jeffrey A. Drebin;David C. Linehan;Farrokh Dehdashti

  • Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.

    Jeffrey Bradley;Wade L. Thorstad;Sasa Mutic;Tom R. Miller

  • A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.

    K.S.Clifford Chao;Walter R Bosch;Sasa Mutic;Jason S Lewis

  • Lymph Node Staging by Positron Emission Tomography in Patients With Carcinoma of the Cervix

    Perry W. Grigsby;Barry A. Siegel;Farrokh Dehdashti

  • Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.

    Joanne E. Mortimer;Farrokh Dehdashti;Barry A. Siegel;Kathryn Trinkaus

  • In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM

    Farrokh Dehdashti;Mark A. Mintun;Jason S. Lewis;Jeffrey Bradley

  • Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.

    Farrokh Dehdashti;Perry W Grigsby;Mark A Mintun;Jason S Lewis

  • FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

    Kevin L. Berger;Siobhan A. Nicholson;Farrokh Dehdashti;Barry A. Siegel

  • Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum

    Mark H. Whiteford;Heather M. Whiteford;Laurence F. Yee;Olagunju A. Ogunbiyi

  • Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography

    F L Flanagan;F Dehdashti;B A Siegel;D D Trask

  • Positron Tomographic Assessment of Estrogen Receptors in Breast Cancer: Comparison with FDG-PET and In Vitro Receptor Assays

    Dehdashti F;Mortimer Je;Siegel Ba;Griffeth Lk

  • Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.

    M S Cohen;N Arslan;F Dehdashti;G M Doherty

  • The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.

    Elizabeth A. Kidd;Barry A. Siegel;Farrokh Dehdashti;Perry W. Grigsby

  • 11C-Acetate PET Imaging of Prostate Cancer: Detection of Recurrent Disease at PSA Relapse

    Nobuyuki Oyama;Tom R Miller;Farrokh Dehdashti;Barry A Siegel

  • Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.

    Elizabeth A. Kidd;Barry A. Siegel;Farrokh Dehdashti;Janet S. Rader

  • 64Cu-TETA-Octreotide as a PET Imaging Agent for Patients with Neuroendocrine Tumors

    C J Anderson;F Dehdashti;P D Cutler;S W Schwarz

  • Positron emission tomographic assessment of 'metabolic flare' to predict response of metastatic breast cancer to antiestrogen therapy

    Farrokh Dehdashti;Fidelma L. Flanagan;Joanne E. Mortimer;John A. Katzenellenbogen

  • Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.

    Julie K. Schwarz;Barry A. Siegel;Farrokh Dehdashti;Perry W. Grigsby

  • 18F-FDG PET Definition of Gross Tumor Volume for Radiotherapy of Non–Small Cell Lung Cancer: Is a Single Standardized Uptake Value Threshold Approach Appropriate?

    Kenneth J. Biehl;Feng Ming Kong;Farrokh Dehdashti;Jian Yue Jin

  • Positron Tomographic Assessment of 16α-[18F] Fluoro-17β-Estradiol Uptake in Metastatic Breast Carcinoma

    Andrea H. McGuire;Farrokh Dehdashti;Barry A. Siegel;Alan P. Lyss

Frequent Co-Authors

Barry A. Siegel
Barry A. Siegel Washington University in St. Louis
Perry W. Grigsby
Perry W. Grigsby Washington University in St. Louis
Michael J. Welch
Michael J. Welch Washington University in St. Louis
David G. Mutch
David G. Mutch Washington University in St. Louis
Jason S. Lewis
Jason S. Lewis Memorial Sloan Kettering Cancer Center
John A. Katzenellenbogen
John A. Katzenellenbogen University of Illinois at Urbana-Champaign
feng gao
feng gao Duke University
Feng Gao
Feng Gao Linköping University
Mark A. Mintun
Mark A. Mintun University of Pennsylvania
Adam S. Kibel
Adam S. Kibel Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The pathway to a career in medicine isn’t limited to becoming a physician. There is a wide range of related online degree programs and bridge pathways that can help you launch or advance your healthcare career.

If you’re interested in the administrative or technical side of healthcare, accredited medical billing and coding schools with financial aid offer flexible options for entering the workforce quickly. For those looking to move into management, a health care administration degree can lead to rewarding leadership roles.

Nursing remains one of the most popular healthcare professions. Not all schools require standardized tests for entry—learn more, including about do you have to take the teas test to get into nursing school. Additionally, many working nurses can accelerate their careers through adn to fnp bridge programs, which pave the way from an associate degree to becoming a family nurse practitioner.

These alternatives and bridge programs make healthcare careers more accessible, allowing you to pursue specialized roles or leadership positions through online study.

Best Scientists Citing Farrokh Dehdashti

Trending Scientists

Recently Published Articles